Literature DB >> 24193363

Comment on Campana et al.: radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence.

Samer Ezziddin1, Amir Sabet, Charlotte Jane Yong-Hing, Hans-Jürgen Biersack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24193363     DOI： 10.1007/s00259-013-2599-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors.

Authors:  Dik J Kwekkeboom; Jaap J Teunissen; Willem H Bakker; Peter P Kooij; Wouter W de Herder; Richard A Feelders; Casper H van Eijck; Jan-Paul Esser; Boen L Kam; Eric P Krenning
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

2.  Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers.

Authors:  Anna Imhof; Philippe Brunner; Nicolas Marincek; Matthias Briel; Christian Schindler; Helmut Rasch; Helmut R Mäcke; Christoph Rochlitz; Jan Müller-Brand; Martin A Walter
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

3.  Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy.

Authors:  Samer Ezziddin; Martin Opitz; Mared Attassi; Kim Biermann; Amir Sabet; Stefan Guhlke; Holger Brockmann; Winfried Willinek; Eva Wardelmann; Hans-Jürgen Biersack; Hojjat Ahmadzadehfar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-18       Impact factor: 9.236

4.  Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence.

Authors:  Davide Campana; Gabriele Capurso; Stefano Partelli; Francesca Nori; Francesco Panzuto; Domenico Tamburrino; Giulia Cacciari; Gianfranco Delle Fave; Massimo Falconi; Paola Tomassetti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-26       Impact factor: 9.236
  4 in total
  1 in total

1.  Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al.

Authors:  Davide Campana; Gianfranco Delle Fave; Massimo Falconi; Paola Tommassetti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.